Immunovant, Inc. · NASDAQ:IMVT
Deep Track Capital, LP reported a 5.59% stake in Immunovant, Inc. (Schedule 13G)
Event Mar 19, 2025 · Filed Mar 26, 2025
Deep Track Capital, LP reported a 5.59% stake in Immunovant, Inc., 9,500,000 shares, as a passive investor on Mar 19, 2025. Filed Mar 26, 2025 (Schedule 13G).
- Stake
- 5.59%
- Shares
- 9,500,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 5.59% | 9,500,000 |
| Deep Track Biotechnology Master Fund, Ltd. | 5.59% | 9,500,000 |
| David Kroin | 5.59% | 9,500,000 |
Source
Related
- Immunovant, Inc.
- Deep Track Capital, LP
- Immunovant, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Form 4 · Gloria Melanie · Oct 9, 2026
- Form 4 · Stout Jay S · Oct 9, 2026
- Form 4 · Van Tuyl Christopher · Oct 9, 2026
- Form 4 · Venker Eric · Oct 5, 2026
- Form 4 · Van Tuyl Christopher · Sep 25, 2026